WFIRM announcement of a new Innovation Accelerator company – PHC – and a new endeavor called the Clinical Trials Catalyst that will involve two PHC companies, led by ReMDO and WFIRM. Speakers: Gary Green, CEO ReMDO, Anthony Atala, Director WFIRM, Steven Lynum, President of Epredia a division of PHC which is based out of Japan, Eric His, Pathology Chair and Terry Hales, MBA. Held in the collaboration area on 2nd floor Dean Building.

March 2022

Etaluma is collaborating with the RegeneratOR Test Bed to help support start-up and early-stage companies in the regenerative medicine space.

August 2021

RegeneratOR Workforce Development received an awardfrom the National Science Foundation.

WRALTechWire reports on the federal grant given to ReMDO will boost training opportunities for students in regenerative medicine.

Phase Holographic Imaging is collaborating with the RegeneratOR Test Bed

July 2021

ReMDO conducts a national survey to identify gaps and opportunities for regenerative medicine workforce, charged by the National Science Board, and published the results.

June 2021

The RegeneratOR Test Bed has officially launched, bringing together resources to advance the regenerative medicine field nationally and create an economic development engine for the region and the state overall.
Winston-Salem JournalTriad Business Journal and WFDD on the partnership to support startups and advance the field of regenerative medicine. WXII and WGHP also covered the announcement. and WRAL TechWire report on the new test bed launch

March 2021

Dr. Anthony Atala, Director of the Wake Forest Institute for Regenerative Medicine, delivers the keynote address for Oracle’s Health Sciences Connect virtual conferences on March 23 – April 23, 2021.

MedCityNews published article titled “Regenerative medicine is already changing the way drugs are discovered and tested,” covering Dr. Anthony Atala’s work and the Humanoid Sensor Consortium.

November 2020

Regenerative Medicine Manufacturing Society (RMMS) is partnering with STEM CELLS Translational Medicine to build a freely accessible collection of shared resources across three areas: models; cell therapies; and technologies. These resources will bring together the scientific community and highlight how the field of regenerative medicine is uniquely positioned to fight the COVID-19 pandemic.

Medical Device Developments published an article titled “A helping hand” featuring ReMDO CTO Joshua Hunsberger in a Q&A about 3D bioprinting.

August 2020

RMMS published “Regen med therapeutic opportunities for fighting COVID-1” in STEM CELLS Translational Medicine journal.

MTEC Research Highlight – Universal Media Supports Cells Derived from 10 Different Tissue Types

News Archive

February 2020

February 24, 2020 – Webinar: Gaps and Opportunities for Fighting COVID-10 featuring Dr. Anthony Atala (WFIRM): Regenerative Medicine Tools
to Fight COVID, Dr. Martha Lundberg (NHLBI, NIH): NHLBI Efforts for Fighting COVID, Dr. Lucie Low (NCATS, NIH): NCATS Efforts for Fighting COVID, Dr. Mahendra Rao (NYSCF): NYSCF Efforts for Fighting COVID, and Dr. Maria Millan (CIRM): CIRM Efforts for Fighting COVID. Click here to view the full recording.

Key Meeting Archive

  • June 2021—RegMIC & RMMS collocated with RME and WSCS)
  • January 21, 2020—RMMS (collocated with WSCS)
  • May 15, 2019—RegMIC
  • January 22, 2019—RMMS (co-located with WSCS)
  • May 8, 2018—RegMIC
  • January 26, 2018—RMMS (co-located with WSCS)
  • June 13, 2017—RegMIC
  • July 18, 2016—RegMIC
  • February 25, 2016—RegMIC
  • August 27, 2015—RegMIC
  • May 20, 2015 Charlotte NC—RegMIC
  • May 5-7, 2014 Regenerative Medicine Foundation 2014 Conference